DELRAY BEACH, Fla., Sept. 9, 2014 (GLOBE NEWSWIRE) — PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a developer of biological detection and diagnostics solutions, today announced that it has shipped three M-BAND (Microfluidic-based Bioagent Autonomous Networked Detector) systems to Aberdeen Proving Ground (“APG”) in Maryland for continued testing to protect U.S. warfighters as part of The Joint United States Forces Korea Portal and Integrated Threat Recognition (JUPITR) program. APG is recognized as one of the world’s most important research and development, testing and evaluation facilities for military weapons and equipment, and supports military and civilian scientists, research engineers, technicians and administrators.
PositiveID previously announced an agreement with a large government contractor to support the U.S. Department of Defense JUPITR Program, led by the Joint Program Executive Office for Chemical and Biological Defense and supported by the U.S. Army Edgewood Chemical Biological Center, to provide unique biological detection capabilities for advanced bio-surveillance on the Korean peninsula. As part of this program, M-BAND is being tested and evaluated to baseline performance, reliability, maintainability, ease of use, and cost of operation to provide the “best of breed” and most affordable options for the U.S. Army and U.S. Air Force. PositiveID has already shipped one M-BAND unit to the Korean peninsula for testing under the program.
“We are honored to provide our M-BAND systems to support and protect our warfighters and allies overseas,” said William J. Caragol, Chairman and CEO of PositiveID. “We believe that this thorough evaluation of our M-BAND systems will show that our product can provide a critical defense against attacks of bioterror.”
Supporting organizations for JUPITR include the Department of Homeland Security, Office of the Assistant Secretary of Defense for Health Affairs, Health Affairs and Defense Threat Reduction Agency.